1. Allford SL,Hunt BJ, Rose P, Machine S. Guidelines on the diagnosis
and management of the thrombotic microangiopathic haemolytic
anaemias. Br J Haematol 2003;120:556-573.
2. Carmichae DS , Medley DRK .Heparin in thrombotic microangiopathy
Lancet 1966;1:1421-1424.
3. Current concepts in thrombotic thrombocytopenic purpura. Annu
Rev Med 2006; 57: 419-436).
4. Del Zoppo, G.J.: Antiplatelet theraphy in thrombotic thrombocytopenic
purpura. Semin Hematology 1987; 24:32.
5. Elliot MA, Nichols, WL.Thorombotic trombositopenic purpura
and hemolitic uremic syndrome.Mayo Clin Proc 2001;76:1154-
1162.
6. Feldman JD , Mardiney MR ,Unanue ER ,Cutting H .The vascular
pathology of thrombotic thrombocytopenic purpura .An immunohistochemical
and ultra structural study. Lab Invest
1966;15:927-946.
7. GA Rock. KH Shumak. NA Buskard.VS Blanchette.JG Kelton.
RC Nair and RA Spasoff comparison of plasma exchange
with plasma infusion in the treatment of thrombotic thrombocytopenic
purpura canadian Apheresis study group N Eng J Med
1991;325:393-397.
8. James N.George How I treat patients with thrombotic thrombocytopenic
purpura- hmolytic uremic syndrome. Blood 2000
;96:1223-1229.
9. George JN,Gilcher RO,Smith JW , Chandler L, Duvall
D.Thrombotic Thrombocytopenic Purpura – Hemolytic Uremic
Syndrome : diagnosis nand manangement .J Clin Apheresis
1998;13:120-125.
10. Havens ,P.L.,O’Rouke P.P.,Hahn,J.,Higgins,J., Walker,A.M.:Laboratory
and clinical varables to predict outcome in hemolyticüremic
syndrome AJDC 1988;142:961.
11. James N. George, Thorombotic trombositopenic purpura N Engl
J Med 2006;354:1927-3195.
12. Kennedy SS, Zacharsky LR,Beck JR.Thrombotic thrombositopenic
purpura :analysis of 48 unselected cases. Semin Thromb
Hemost 1980;6:341-349.
13. Kutell MA ,Alfrey CP ,Hetting RA.TTP treatment N Engl J Med
1971;285:971-972.
14. Melnyk, A.M.S.,Solez K., Kjellstrand, C.M.:Hemolytic uremic
syndrome in adults. Arch Intern Med 1995;155:2077.
15. Miller,J.M., Pastorek ,JG.:Thrombotic thrombocytopenic purpura
and hemolytic üremic syndrome in pregnancy.Clin Obstet
Gynecol 1991;34:41.
16. Neame PB.Immunologic and other factors in thrombotic thrombocytopenic
purpura (TTP). semin Thromb Hemost 1980;6:416-
429.
17. Ponticelli,C.,Rivolta ,E.,Imbasciati ,E., Rossi,E., Mannucci,
P.M.:Hemolytic üremic syndrome. Arch Intern Med 1980;
140:335.
18. Rock ,G.A.,Shumak,K.H.,Buskard ,N.A.: Comparision of plasma
Exchange with plasma infusion the treatment of TTP N Eng J
Med 1991;325:326.
19. Rock G ,Porta C , Bobbio-Pallavicini E.Thrombotic thrombocytopenic
purpura treatment in year 2000.Haematologica 2000;
85:410-419.
20. Sadler JE,Moake JL. Recent advances in thrombotic trombocytopenic
purpura American Society of Hematology, 2004; 407-423.
21. Terrell DR, Williams LA, Vesely SK,Lammle B, Hovinga JA,
George JN,The incidence of thrombotic thrombocytopenic purpura-
hemolytic uremic syndrome: all patients, idiopathic patients,
and patients with severe ADAMTS-13 deficiency. J Thromb Haemost
2005; 3:1432-1436.
22. Weinstein ,L.: Syndrome of hemolysis, elevated liver enzymes
and low platelet count : Asevere consequence of hypertension in
pregnancy. Am J Obstet Gynecol 1982; 142:159.
Thank you for copying data from http://www.arastirmax.com